Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5897
    -0.0008 (-0.14%)
     
  • NZD/EUR

    0.5525
    -0.0020 (-0.36%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    82.16
    -0.57 (-0.69%)
     
  • GOLD

    2,392.00
    -6.00 (-0.25%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,837.65
    -39.40 (-0.50%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,738.41
    -98.99 (-0.55%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    91.1180
    -0.1360 (-0.15%)
     

GW Pharmaceuticals: Recommendations and Market Capitalization

GW Pharmaceuticals: Recommendations and Market Capitalization

GW Pharmaceuticals (GWPH) has developed prescription medicines derived from the cannabis plant for the treatment of spasticity from multiple sclerosis. Its portfolio includes clinical stage cannabinoid products focused on the treatment of neurological conditions.